Harpoon Therapeutics

-$0.64 (-5.92%) Today
+$0.73 (+7.18%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HARP and other ETFs, options, and stocks.

About HARP

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.

CEO
Gerald McMahon
Employees
78
Headquarters
South San Francisco, California
Founded
2015

HARP Key Statistics

Market Cap
429.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
607.65K
High Today
$10.89
Low Today
$9.87
Open Price
$10.89
Volume
1.23M
52 Week High
$25.24
52 Week Low
$9.87

HARP Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure